Total Other Income - Intercept Pharmaceuticals Inc (F:I4P) - Alpha Spread
I

Intercept Pharmaceuticals Inc
F:I4P

Watchlist Manager
Intercept Pharmaceuticals Inc
F:I4P
Watchlist
Price: 17.52 EUR Market Closed
Market Cap: 732.8m EUR
Have any thoughts about
Intercept Pharmaceuticals Inc?
Write Note

Intercept Pharmaceuticals Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intercept Pharmaceuticals Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
I
Intercept Pharmaceuticals Inc
F:I4P
Total Other Income
$14.2m
CAGR 3-Years
30%
CAGR 5-Years
18%
CAGR 10-Years
54%
Abbvie Inc
NYSE:ABBV
Total Other Income
-$3.4B
CAGR 3-Years
21%
CAGR 5-Years
-10%
CAGR 10-Years
-65%
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$91m
CAGR 3-Years
0%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$1B
CAGR 3-Years
248%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$58m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$15.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Intercept Pharmaceuticals Inc's Total Other Income?
Total Other Income
14.2m USD

Based on the financial report for Sep 30, 2023, Intercept Pharmaceuticals Inc's Total Other Income amounts to 14.2m USD.

What is Intercept Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
54%

Over the last year, the Total Other Income growth was 520%. The average annual Total Other Income growth rates for Intercept Pharmaceuticals Inc have been 30% over the past three years , 18% over the past five years , and 54% over the past ten years .

Back to Top